|||  Journal title: Audiology | Publisher: Tehran University of Medical Sciences | Website: http://aud.tums.ac.ir | Email: aud@tums.ac.ir   |||
   [Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Registration :: Submission :: Current Issue :: Archive :: Contact :: Search ::
Main Menu
Home::
Journal Information::
Articles archive::
Indexing & Abstracting::
For Authors::
For Reviewers::
Contact us::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations21531230
h-index2113
i10-index6629

..
:: Search published articles ::
Showing 1 results for Thalassemic Patients

Sorayya Nili, Ali Reza Karimi Yazdi, Ramezan Ali Sharifian, Shoreh Jalaei,
Volume 11, Issue 1 (5-2002)
Abstract

Objective: The purpose of study was identify hearing loss in thalassemic patients with history of Desferrioxamine (DFO) therapy. This study was carried out in a cross-sectional descriptive survey on 195 thalassemic patients (3-30 years old) in Gazvin Thalassemia center and Tehran pediatrics&apos medical center.
Methods: The patients underwent routine otolaryngologic history and physical examination, along with standard pure-tone audiometry.
Results: Hearing loss was present in 43.1% of patients. 16% of patients had conductive hearing loss and 4.6% of patient had sensory neural hearing loss. 22.5% of thalassemic patients had high-frequency sensory neural hearing loss and more importantly, high-frequency hearing loss attributable to Desferrioxamine ototoxicity was present in 12% of patients. Furthermore, these evaluations showed that there is a significant relationship between hearing loss and DFO usage and hearing loss too. There is no significant relationship between hearing loss and ferritin level between hearing loss and age of DFO usage too.
Conclusion: Management of these patients requires proper dosing of Desferrioxamine, along with regular otolaryngolgic and audiometric follow-up in order to prevent the effect of ototoxicity of desferal.



Page 1 from 1     

شنوایی شناسی - دانشگاه علوم پزشکی تهران Bimonthly Audiology - Tehran University of Medical Sciences
Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Persian site map - English site map - Created in 0.05 seconds with 29 queries by YEKTAWEB 4657